Expert Review of Vaccines
Volume 23, 2024 - Issue 1
Original Research
The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis
Daisuke Kuraia Department of General Medicine, Kyorin University School of Medicine, Tokyo, Japan
https://orcid.org/0000-0001-9492-8798View further author information
https://orcid.org/0000-0001-9492-8798View further author information, Akiko Mizukamib GSK, Tokyo, JapanCorrespondence[email protected]
https://orcid.org/0000-0002-9507-199XView further author information
https://orcid.org/0000-0002-9507-199XView further author information, Victor Precklerc GSK, Wavre, Belgiumhttps://orcid.org/0000-0002-4780-8299View further author information
https://orcid.org/0000-0002-4780-8299View further author information, Frederik Verelstc GSK, Wavre, Belgiumhttps://orcid.org/0000-0001-8399-743XView further author information
https://orcid.org/0000-0001-8399-743XView further author information, Daniel Molnarc GSK, Wavre, Belgiumhttps://orcid.org/0000-0002-6785-3812View further author information
https://orcid.org/0000-0002-6785-3812View further author information, Taizo Matsukib GSK, Tokyo, Japanhttps://orcid.org/0000-0002-0591-4261View further author information
https://orcid.org/0000-0002-0591-4261View further author information, Yufan Hod GSK, Singapore, Singaporehttps://orcid.org/0000-0003-1943-5533View further author information
https://orcid.org/0000-0003-1943-5533View further author information & Ataru Igarashie Department of Public Health, Yokohama City University, Kanagawa, Japan;f Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japanhttps://orcid.org/0000-0001-6307-6916View further author information
https://orcid.org/0000-0001-6307-6916View further author information show all